๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Ovarian Carcinoma

ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site๐Ÿ“ Liverpool Pierian Biosciences ยท Tests: No intervention A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy NCT07144826EARLY Phase 11 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site๐Ÿ“ Tianjin Jacobio Pharmaceuticals Co., Ltd. ยท Tests: JAB-8263, JAB-8263 A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer NCT07023484Phase 26 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen๐Ÿ“ Chai Wan The University of Hong Kong ยท Tests: KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. NCT07389239Phase 1, Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Decitabine, Cyclophosphamide Conditioning, NY-ESO-1 TCR/ dnTGFฮฒRII, Aldesleukin A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites๐Ÿ“ Maumee๐Ÿ“ Portland๐Ÿ“ Fairfax TwoStep Therapeutics, Inc. ยท Tests: TS-104 A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites๐Ÿ“ Newport Beach๐Ÿ“ Stanford๐Ÿ“ Miami Eli Lilly and Company ยท Tests: LY4337713 Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments NCT06799637Phase 1, Phase 224 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Beijing Evopoint Biosciences Inc. ยท Tests: XNW28012 A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors NCT06666270Phase 12 sites๐Ÿ“ Zhengzhou๐Ÿ“ Shanghai Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd ยท Tests: SYN818 A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites๐Ÿ“ Ryde๐Ÿ“ Sydney๐Ÿ“ Westmead EtiraRx Australia Pty Ltd ยท Tests: ERX-315 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation NCT04890613Phase 18 sites๐Ÿ“ Santa Monica๐Ÿ“ Tampa๐Ÿ“ Boston Senhwa Biosciences, Inc. ยท Tests: CX-5461 Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study. NCT06614790n/a12 sites๐Ÿ“ Bialystok๐Ÿ“ Gdansk๐Ÿ“ Gliwice Pomeranian Medical University Szczecin ยท Tests: Niraparib 200/300 MG Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites NCT07435701Phase 1, Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: SK-NK Cell Injection Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Miami Beach Faeth Therapeutics ยท Tests: Sapanisertib, Serabelisib, Paclitaxel EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EBNK-001 + IL-15 + Pembrolizumab A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site๐Ÿ“ Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-8989 Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer NCT07636200NA2 sites๐Ÿ“ Aurora๐Ÿ“ Boulder University of Colorado, Boulder ยท Tests: Written Exposure-Based Coping Intervention (EASE), Usual Care Control Condition Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer NCT07125391Phase 21 site๐Ÿ“ Hefei Bai-Rong Xia ยท Tests: Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites๐Ÿ“ Amberg๐Ÿ“ Augsburg๐Ÿ“ Bad Homburg AGO Study Group ยท Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors NCT06769152Phase 21 site๐Ÿ“ Ji'nan Shanghai Henlius Biotech ยท Tests: HLX43 Clinical Pre-screening Protocol for Ovarian Cancer NCT03877796n/a9 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Albuquerque Allarity Therapeutics ยท Tests: Drug Response Predictorยฎ (DRP) A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Eli Lilly and Company ยท Tests: LY4052031, Pembrolizumab Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT07665515Phase 110 sites๐Ÿ“ Cambridge๐Ÿ“ Edinburgh๐Ÿ“ Glasgow Epitopea Ltd ยท Tests: CryptiVax-1001 Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer NCT05652283Phase 21 site๐Ÿ“ Hefei Bai-Rong Xia ยท Tests: Pamiparib, Surufatinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy